The Leflunomide test using Liquid Chromatography coupled with Mass Spectrometry (LC-MS/MS) is an important tool for measuring the drug levels in the blood. This test is primarily used to monitor the effectiveness of treatment in conditions like rheumatoid arthritis, helping to adjust dosages and avoid potential side effects. The significance of this test lies in its ability to accurately measure very low levels of Leflunomide, which helps assess the patient's response to treatment. The test can be performed after starting the treatment or when adjusting the dosage to ensure that the levels remain within the ideal therapeutic range. Based on the results, doctors can make informed decisions about modifying the treatment plan, enhancing the effectiveness of therapy, and improving the quality of life for patients.